Back to search
Fulminant Clostridium Difficile Colitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Fulminant Clostridium Difficile Colitis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Fulminant Clostridium Difficile Colitis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A new medication, Bezlotoxumab, has been approved for treatment of recurrent Clostridium difficile diarrhea by the U.S. Food and Drug Administration. The way th…
LAY SUMMARY Clostridium Difficile (C.difficile) is a bacterial infection that can cause an inflammation of the colon, (C.difficile colitis). This sometimes pro…
The investigators hypothesize that minimally invasive ileal diversion with intraoperative colonic lavage using a high volume polyethylene glycol/electrolyte sol…